🇺🇸 FDA

Company profile · Sponsor

PharmaEssentia

CF5EE33 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

PharmaEssentia (CF5EE33) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CF5EE33
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. P1101

    PharmaEssentia

    Polycythemia Vera (PV)

    phase 3 small molecule completed

    1 trial

  2. Ropeginterferon alfa-2b

    PharmaEssentia

    Primary Myelofibrosis

    phase 3 mab active

    1 trial

Frequently asked questions

What is PharmaEssentia?

PharmaEssentia (CF5EE33) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does PharmaEssentia sponsor?

We track 2 ClinicalTrials.gov-linked programs for PharmaEssentia, including P1101 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does PharmaEssentia company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.